FIBROSIS
Clinical trials for FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new FIBROSIS trials appear
Sign up with your email to follow new studies for FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a blood pressure drug reverse liver damage in hepatitis c?
Disease control CompletedThis study tested whether adding prazosin, a drug usually used for high blood pressure, to standard hepatitis C treatment could reduce liver scarring. 112 adults with chronic hepatitis C (genotype 1 or 4) and severe liver fibrosis took part. Researchers measured changes in liver …
Matched conditions: FIBROSIS
Phase: PHASE2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common supplement help fatty liver disease?
Disease control CompletedThis early-phase study tested an oral drug called idebenone in 53 adults with non-alcoholic steatohepatitis (NASH) and mild-to-moderate liver scarring. The main goal was to check safety and tolerability, while also looking for signs that the drug might reduce liver stiffness and …
Matched conditions: FIBROSIS
Phase: PHASE1, PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a growth hormone help people with End-Stage liver disease?
Disease control CompletedThis study tested whether giving growth hormone to people with decompensated liver cirrhosis (advanced liver scarring) could improve their health and survival. The trial included 96 adults with this condition. Researchers measured how long patients survived without major complica…
Matched conditions: FIBROSIS
Phase: PHASE2, PHASE3 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug shows promise against fatty liver and scarring
Disease control CompletedThis phase 2b trial tested whether saroglitazar magnesium can help people with nonalcoholic steatohepatitis (NASH) and liver fibrosis. 189 adults took either a 2 mg or 4 mg dose of the drug or a placebo daily for several months. The main goal was to see if the drug could resolve …
Matched conditions: FIBROSIS
Phase: PHASE2 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Electric needle therapy eases calf injury pain?
Symptom relief CompletedThis study looked at whether a treatment called percutaneous electrolysis (using a tiny electric current through a needle) can help people with calf muscle tears feel better and move more easily. About 75 adults with a torn medial gastrocnemius muscle were split into three groups…
Matched conditions: FIBROSIS
Phase: NA • Sponsor: University of Salamanca • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC